News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,320 Results
Type
Article (41067)
Company Profile (284)
Press Release (650969)
Section
Business (205129)
Career Advice (2158)
Deals (35518)
Drug Delivery (87)
Drug Development (81393)
Employer Resources (171)
FDA (16234)
Job Trends (14930)
News (346878)
Policy (32702)
Tag
Academia (2593)
Alliances (49582)
Alzheimer's disease (1241)
Approvals (16163)
Artificial intelligence (134)
Bankruptcy (352)
Best Places to Work (11635)
Biotechnology (205)
Breast cancer (120)
Cancer (1101)
Cardiovascular disease (97)
Career advice (1798)
Cell therapy (236)
Clinical research (64641)
Collaboration (390)
Compensation (200)
COVID-19 (2567)
C-suite (94)
Data (1129)
Diabetes (152)
Diagnostics (6232)
Earnings (84959)
Employer resources (150)
Events (110133)
Executive appointments (313)
FDA (16777)
Funding (357)
Gene therapy (184)
GLP-1 (585)
Government (4369)
Healthcare (18906)
Infectious disease (2652)
Inflammatory bowel disease (106)
Interviews (351)
IPO (16339)
Job creations (3653)
Job search strategy (1530)
Layoffs (419)
Legal (7903)
Lung cancer (173)
Manufacturing (180)
Medical device (13303)
Medtech (13308)
Mergers & acquisitions (19258)
Metabolic disorders (402)
Neuroscience (1522)
NextGen Class of 2024 (6609)
Non-profit (4528)
Northern California (1484)
Obesity (232)
Opinion (185)
Patents (103)
People (56701)
Phase I (20094)
Phase II (28476)
Phase III (21218)
Pipeline (461)
Postmarket research (2573)
Preclinical (8606)
Radiopharmaceuticals (239)
Rare diseases (219)
Real estate (5944)
Regulatory (21708)
Research institute (2370)
Resumes & cover letters (366)
Southern California (1307)
Startups (3611)
United States (13576)
Vaccines (561)
Weight loss (168)
Date
Today (44)
Last 7 days (673)
Last 30 days (3717)
Last 365 days (35925)
2024 (32971)
2023 (40368)
2022 (51523)
2021 (56087)
2020 (54534)
2019 (47092)
2018 (35439)
2017 (32467)
2016 (31902)
2015 (37986)
2014 (31654)
2013 (26710)
2012 (28921)
2011 (29557)
2010 (27603)
Location
Africa (740)
Arizona (194)
Asia (37577)
Australia (6194)
California (3343)
Canada (1298)
China (252)
Colorado (148)
Connecticut (153)
Europe (81022)
Florida (463)
Georgia (116)
Illinois (347)
Indiana (198)
Kansas (96)
Maryland (582)
Massachusetts (2626)
Michigan (158)
Minnesota (275)
New Jersey (959)
New York (968)
North Carolina (711)
Northern California (1484)
Ohio (140)
Pennsylvania (849)
South America (1115)
Southern California (1307)
Texas (466)
Utah (90)
Washington State (366)
692,320 Results for "trace ability inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
November 12, 2024
·
5 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity
October 1, 2024
·
3 min read
BioMidwest
Trace Genomics Raises Oversubscribed $10.5 Million Series B, Expanding Reach of Pioneering DNA Soil Intelligence Platform
Trace Genomics, the industry leader in DNA-based soil intelligence, announced its successful Series B funding round at $10.5 million led by existing investors S2G Ventures and Ajax Strategies, as well as new investor Rabo Ventures.
February 20, 2024
·
4 min read
CAR T
CAR T and Related Therapies Home In on Autoimmune Disease
Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.
November 4, 2024
·
9 min read
·
Shawna Williams
Business
Trace Medical & Outset Medical sign long-term distribution agreement for Tablo® Hemodialysis System
Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical to rent the Tablo® Hemodialysis System to Home Medical Equipment (HME) providers.
October 3, 2023
·
4 min read
Press Releases
ACG Inspection awarded GS1 Nigeria Gold Partnership
Track and trace solutions provider to help businesses meet NAFDAC regulations
August 29, 2024
·
1 min read
Pharm Country
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
RespireRx Pharmaceuticals Inc. is pleased to announce that, as part of an ongoing collaboration, a scientist team led by Dr. David Fuller of the University of Florida has published a peer-reviewed research article describing the ability of CX1739.
March 20, 2024
·
14 min read
Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators
Ability Biologics announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor Amplitude Ventures.
June 18, 2024
·
5 min read
Drug Development
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
Prime Medicine, Inc. oday reported new preclinical data demonstrating the ability of its ex vivo Prime Editing program, PM359, to correct a common disease-causing mutation of chronic granulomatous disease (CGD).
May 8, 2024
·
9 min read
1 of 69,232
Next
